Thursday, August 28, 2008

Amgen to End Controversial Anemia-Drug Sales Practices

Amid rising safety concerns, critics have said Amgen's practices resulted in overuse of Aranesp.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)